Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07188948 · ClinicalTrials.gov registry record
In Vivo Cross-Modal Imaging of Skin
A clinical trial of Skin, sponsored by Gabriel Sanchez.
- Recruiting
- Registry status
- 15
- Enrollment target
- 1
- Study location
NCT07188948: Recruiting study of Skin, sponsored by Gabriel Sanchez.
NCT07188948 is a study of Skin that is actively recruiting participants, run by Gabriel Sanchez. The registered enrollment target is 15 participants, below the 64-participant average among 5 other Skin trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07188948, a study of Skin, is actively recruiting participants, sponsored by Gabriel Sanchez.
- RECRUITING
- Registry status
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall objective of this study is to use VIO/FG-30350 ("VIO") to observe microscopic skin structure in people of different skin health at different anatomic locations and correlate microscopic features with macroscopic features.
Primary Outcome
Correlational relationship of: melanin content quantified from noninvasive VIO images with macroscopic skin tone as measured with a colorimeter.
Conditions Studied
Interventions
- DEVICE Skin conditions
- DEVICE Skin Condition
Study Locations (1)
California
- Enspectra Health - Mountain View
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2025-09-02 |
| Est. Completion | 2025-09-30 |
What NCT07188948 shows while recruiting
NCT07188948 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 64-participant average among 5 other Skin trials with a reported enrollment target (77% lower).
The record links to 1 condition, with Skin appearing as the primary indexed condition, and to 2 interventions - of which Skin conditions is the first listed.
NCT07188948 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07188948 about?
NCT07188948 is a clinical study titled "In Vivo Cross-Modal Imaging of Skin". The overall objective of this study is to use VIO/FG-30350 ("VIO") to observe microscopic skin structure in people of different skin health at different anatomic locations and correlate microscopic features with macroscopic features.
What is the current status of trial NCT07188948?
This trial is currently recruiting. The enrollment target is 15 participants. The study started on 2025-09-02. Estimated completion is 2025-09-30.
What conditions does trial NCT07188948 study?
This clinical trial studies the following conditions: Skin.
What interventions are being tested in trial NCT07188948?
The interventions under investigation include: Skin conditions (DEVICE), Skin Condition (DEVICE).
Who is sponsoring clinical trial NCT07188948?
This trial is sponsored by Gabriel Sanchez, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07188948 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Trial of Ixazomib for Kaposi Sarcoma
RECRUITING · Phase 2
-
See the Impact Beem's Blue Light Therapy Has on Your Skin Health!
RECRUITING · NA
-
Lumenato Nutritional Supplement on Skin Appearance
COMPLETED · NA
-
The Effect of Topical Almond Oil vs. Topical Retinol on The Appearance of Facial Wrinkles
COMPLETED · NA
-
A Clinical Study to Evaluate the Efficacy and Consumer Perception of Lumenato
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI